Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Kevin King, Blaine Bowman

Premium

Kevin King has been named to serve on the board of directors at medical diagnostics company iRhythm Technologies. King was president and CEO at Affymetrix from 2007 to 2011, and before that held the same position at Thomson Healthcare. He also was an executive at GE Healthcare and Hewlett Packard's Medical Products Group.


Blaine Bowman has joined the board of directors at Altera. Bowman currently is on the board of Illumina and he formerly was president, CEO, and chairman of chromatography technology company Dionex, where he had a 28-year career.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.